These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3694979)

  • 1. [Clinical application of flow cytometry in urology. 4. The role of the flow cytometric DNA-histogram as a prognostic factor of renal cell carcinomas].
    Tachibana M; Jitsukawa S; Nakajima J; Iigawa T; Deguchi N; Baba S; Nakazono M; Hata M; Tazaki H
    Nihon Hinyokika Gakkai Zasshi; 1987 May; 78(5):816-21. PubMed ID: 3694979
    [No Abstract]   [Full Text] [Related]  

  • 2. [Flow cytometric DNA analysis of renal cell carcinoma and its relationship to tumor grading, tumor stage and prognosis].
    Hara H; Tanioka F
    Rinsho Byori; 1993 Jun; Suppl 94():76-88. PubMed ID: 8361010
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic parameters of renal cell carcinoma. Clinicopathologic and DNA image cytometric analysis in 133 pT3a cases.
    Steinbach F; Stöckle M; Kiewel R; Störkel S; Stein R; Hohenfellner R
    Eur Urol; 1993; 24(2):279-85. PubMed ID: 8375451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma.
    Yokogi H
    Cancer; 1996 Aug; 78(4):819-26. PubMed ID: 8756377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flow cytometric analysis of renal cell carcinoma].
    Lü GH
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):27-9. PubMed ID: 2364867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical application of flow cytometry in urology. 2. Comparison between bladder biopsy specimens and bladder irrigation samples by flow cytometric DNA-histogram].
    Tachibana M; Nakamura S; Shibayama T; Jitsukawa S; Deguchi N; Baba S; Nakazono M; Hata M; Tazaki H
    Nihon Hinyokika Gakkai Zasshi; 1986 Nov; 77(11):1857-63. PubMed ID: 3573469
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of flow cytometric, static cytometry and tumor cytogenetic investigation results human renal cell carcinomas].
    Krech RH; Baretton G; Fonatsch C; Diebold J; Früchtnicht W; Löhrs U
    Verh Dtsch Ges Pathol; 1990; 74():228-32. PubMed ID: 1708590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and flow cytometric analyses of renal cell carcinomas with reference to incidental or non-incidental detection.
    Sasaki Y; Homma Y; Hosaka Y; Tajima A; Aso Y
    Jpn J Clin Oncol; 1994 Feb; 24(1):32-6. PubMed ID: 8126918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA cytometry in renal cell carcinoma.
    Nenning H; Rassler J; Minh DH
    Gen Diagn Pathol; 1996 Mar; 141(3-4):243-7. PubMed ID: 8705789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of flow and image DNA cytometry in prediction of patient prognosis in surgically resected small cell lung cancer.
    Carey FA; Gray E; O'Mahony M; Craig SR; Salto-Tellez M; Lamb D
    Anal Cell Pathol; 1996 Dec; 12(3):137-43. PubMed ID: 9025990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromodeoxyuridine and deoxyribonucleic acid bivariate analysis in human renal cell carcinoma. Does flow cytometric determination predict malignant potential or prognosis of patients with renal cell carcinoma?
    Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
    Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S38-47. PubMed ID: 1575219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal cell carcinoma: DNA cytometry and its clinical significance. An 8 year survival study].
    al-Abadi H; Nagel R
    Helv Chir Acta; 1991 Sep; 58(3):331-4. PubMed ID: 1769855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
    Eskelinen M; Lipponen P; Nordling S
    Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic, flow cytometric, and ultrastructural studies of twenty-nine nonfamilial human renal carcinomas.
    Wolman SR; Camuto PM; Golimbu M; Schinella R
    Cancer Res; 1988 May; 48(10):2890-7. PubMed ID: 3359446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
    Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
    Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
    Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
    Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of DNA of renal cell carcinomas by flow cytometry].
    Chassevent A
    Arch Anat Cytol Pathol; 1992; 40(5-6):307-11. PubMed ID: 1304118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kidney parenchyma carcinoma--diagnosis. German Society of Urology].
    Urologe A; 1998 May; 37(3):328-41. PubMed ID: 9646432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.